Dr. Jaspriya Bal
Associate Director - Nuclear Medicine, Cancer Care / Oncology
Nuclear Medicine, Cancer Care / Oncology
Experience: 15+ Years
Share Doctor Profile
To Book an Appointment
Call Us+91 926 888 0303To Book an Appointment
Call Us+91 926 888 0303About Dr. Jaspriya Bal
Work Experience
- Dr. Jaspriya Bal is currently working at Max Healthcare
- A Nuclear Medicine Physician with special interest in Radionuclide therapy of various types of cancers. Dr. Jaspriya Bal has more than 10 years of experience to her credit. Trained in a wide range of diagnostic and therapeutic nuclear medicine procedures, she is an expert in PET-CT & SPECT imaging.
Education & Training
- Fellow of Asian Board of Nuclear Medicine (FANMB)
- Level 1 ICPO Certification in Radiomolecular Precision Oncology and Theranostics
- Certification in Eurolearn for Cardiac Amyloidosis Imaging by ESMIT
- Radiation Safety Officer Level II (RSO-II)
- DRM, Institute of Nuclear Medicine and Allied Sciences, Delhi
- MBBS, Maulana Azad Medical College, Delhi University
Memberships
- Life Member of Society of Nuclear Medicine (India) (SNMI)
- Life Member of Association of Nuclear Medicine Physicians of India (ANMPI)
- Member of Indian Thyroid Society (ITS)
- Indian Ambassador of Oncidium Foundation for Theranostics and RLTconnect
- Member of Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- Member of American College of Nuclear Medicine (ACNM)
- Member of World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
- Member of WE (Women Empowerment group) of European Association of Nuclear Medicine (EANM)
- Member of American Society of Nuclear Cardiology (ASNC)
- Life Member of European Society of Medical Oncologists (ESMO)
Awards
- Role of F-18 FDG in diagnosis of tumor thrombus” in Society of Nuclear Medicine conference at Jaipur, 2009.
- Paper presentation on “Comparative analysis of 18F-NaF, 18F-FDG and Cocktail 18F-NaF/18F-FDG PET/CT for evaluation of malignancy” in Society of Nuclear Medicine conference at PGI Chandigarh,2010.
- Comparison of F-18 FDG and C-11 Methionine PET/CT for demonstration of subependymal deposit in a treated case of glioblastoma multiform-case report.
- Poster presentation on Comparative evaluation of C-11 Methionine (MET-PET) and F-18 flurodeoxyglucose (FDG) PET/CT for detection of recurrent brain tumors” in Society of Nuclear Medicine conference at PGI Chandigarh, 2010.
- Research topic and thesis on carcinoma parathyroid, Hodgkin’s & Non-Hodgkin’s lymphoma correlation with imaging (Current & Ongoing research)
- Role of F-18 FDG PET-CT in evaluation of bone marrow involvement in Lymphomas- Indian Cancer Congress, Nov 2014
- Palliative chemotherapy (CT) with or without cetuximab (CTX) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): An Indian retrospective analysis, November 2018, Annals of Oncology, 29(suppl_9)
- Utility of Gallium-68 PSMA PET/CT scan for staging and treatment of prostate cancer in contemporary era: Study from a tertiary care cancer centre in a developing country; November 2018 Annals of Oncology, 29(suppl_9)
- Clinicoradiological Profile and Treatment Outcomes in Prostate Cancer at a Tertiary Care Cancer Center in India March 2020Indian Journal of Medical and Paediatric Oncology 41(2):187
- Case report- Primary hyperparathyroidism with Brown tumors masquerading skeletal metastases – Role of functional imaging in diagnosis and management; October 2019 Journal of Clinical and Translational Endocrinology Case Reports
- All That Lights-Up is not Lymphoma October 2019 – Indian Journal of Hematology and Blood Transfusion
- Pleural Mesothelioma with Peritoneal Involvement: Diagnosed on 18F-FDG Positron Emission Tomography/Computed Tomography; Indian Journal of Respiratory Medicine, Vol 8
- Accuracy of Ga68PSMA PET-CT in detecting lymph nodal metastastses in intermediate to high risk Adenocarcinoma prostate at initial evaluation prior to radical prostatectomy and correlation with final histopathology- A retrospective analysis, Journal of Nuclear Medicine June 2023, 64 (supplement 1) P175;
- A Rare Case of Renal Malakoplakia Incidentally Detected on 18F-FDG PET/CT in a Patient With Concomitant Breast Cancer and Lymphoma; Ritwik Wakankar 1, Jaspriya Bal, Kanchan Sharma, Pankaj Dougall; Clin Nucl Med. 2024 Jun 3.doi:10.1097.
- F18 FDG Imaging in a Rare case of Solitary Primary Iliac Bone Lymphoma; Ritwik Wakankar; Jaspriya Bal, Pankaj Dougall; Indian Journal of Haematology and Blood Transfusion; 26/August/2024
- Paraneoplastic Proliferative Myositis on 18F-FDG PET/CT. Wakankar, Ritwik MD; Bal, Jaspriya DRM; Dougall, Pankaj DRM, FICNM. Clinical Nuclear Medicine, October 30, 2024
- Reviewer – BJR Case Reports
- Reviewer – Indian Journal of Urology
- Most Trusted Nuclear Medicine Physician Award, Delhi NCR, April 2023
- Max Gem of Excellence Award, 2018
Speciality Interest
- Molecular Imaging (18F and 68Ga based PET-CT imaging)
- Targeted radiology and therapies- Iodine 131, Lutetitium therapies (PSMA, PRRT, FAPI), Yetterium therapies
- Nuclear Cardiology and Neurology Imaging
Frequently Asked Questions
- Fellow of Asian Board of Nuclear Medicine (FANMB)
- Level 1 ICPO Certification in Radiomolecular Precision Oncology and Theranostics
- Certification in Eurolearn for Cardiac Amyloidosis Imaging by ESMIT
- Radiation Safety Officer Level II (RSO-II)
- DRM, Institute of Nuclear Medicine and Allied Sciences, Delhi
- MBBS, Maulana Azad Medical College, Delhi University
Showcasing their extensive education and training.
- Monday : 9:00 am – 1:00 pm
- Tuesday : 9:00 am – 3:00 pm
- Thursday :1:00 pm – 4:00 pm
Booking an online appointment with Dr. Jaspriya Bal is easy. You can book from our website or the Max my Health app, or call us at +91 926 888 0303.
OPD Timings
- Monday : 9:00 am – 1:00 pm
- Tuesday : 9:00 am – 3:00 pm
- Thursday :1:00 pm – 4:00 pm